DrugPatentWatch Database Preview
Drugs in Development Information for Tocotrienol
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Tocotrienol?
Tocotrienol is an investigational drug.
There have been 18 clinical trials for Tocotrienol.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Ovarian Neoplasms, Pancreatic Neoplasms, and Atrial Fibrillation. The leading clinical trial sponsors are Vejle Hospital, H. Lee Moffitt Cancer Center and Research Institute, and Texas Tech University Health Sciences Center.
There are thirty-one US patents protecting this investigational drug and one hundred and ninety-nine international patents.
Summary for Tocotrienol
| US Patents | 31 |
| International Patents | 199 |
| US Patent Applications | 46 |
| WIPO Patent Applications | 22 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 0 |
Recent Clinical Trials for Tocotrienol
| Title | Sponsor | Phase |
|---|---|---|
| Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer | Vejle Hospital | Phase 2 |
| Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation | INSTITUT JANTUNG NEGARA | Phase 2/Phase 3 |
| Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation | Monash University Malaysia | Phase 2/Phase 3 |
Clinical Trial Summary for Tocotrienol
Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol
US Patents for Tocotrienol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tocotrienol | Start Trial | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (New York, NY) | Start Trial |
| Tocotrienol | Start Trial | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (New York, NY) | Start Trial |
| Tocotrienol | Start Trial | Antioxidant compositions for coating substrates, substrates coated with the same and methods for inhibiting the oxidation of such compositions applied to a substrate | PPG Industries, Inc. (Pittsburgh, PA) | Start Trial |
| Tocotrienol | Start Trial | Substrates coated with antioxidant compositions and method for inhibiting the oxidation of such compositions applied to a substrate | PPG Industries, Inc. (Pittsburgh, PA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tocotrienol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tocotrienol | Canada | 2026713 | 2009-10-04 | Start Trial |
| Tocotrienol | European Patent Office | 0421419 | 2009-10-04 | Start Trial |
| Tocotrienol | Hungary | 207442 | 2009-10-04 | Start Trial |
| Tocotrienol | Hungary | 906297 | 2009-10-04 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
